| Literature DB >> 35864343 |
Yvonne Kienberger1, Robert Sassmann2, Florian Rieder1, Tim Johansson3, Helmut Kässmann4, Christian Pirich4, Anton Wicker1, Josef Niebauer1,5.
Abstract
PURPOSE: Osteopenia is common in postmenopausal women and effective interventions increasing or stabilizing bone mineral density (BMD) to prevent fractures are urgently needed.Entities:
Keywords: Bone mineral density; Osteopenia; Postmenopausal; Resistance training; T-score; Whole body vibration training
Mesh:
Year: 2022 PMID: 35864343 PMCID: PMC9560973 DOI: 10.1007/s00421-022-05010-5
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.346
Fig. 1Timeline
Fig. 2Consort chart illustrating participants recruitment and retention
Baseline characteristics of patients by group
| VT ( | RT ( | CG ( | ||
|---|---|---|---|---|
| Age [years], mean (SD) | 56.1 (5.1) | 62.8 (6.8) | 58.7 (8.2) | 0.0111 |
| Body mass index [kg/m2], mean (SD) | 21.6 (2.1) | 25.5 (4.0) | 24.0 (3.7) | 0.0031 |
| Osteopenia (%), total hip left, T-score between − 1.0 and − 2.5 | 66.7 | 45.5 | 50.0 | 0.3822 |
| Osteopenia (%), lumbar spine, T-score between − 1.0 and − 2.5 | 83.3 | 90.5 | 90.5 | 0.7322 |
| T-score total hip left, mean (SD) | − 1.16 (0.58) | − 0.84 (0.70) | − 0.92 (0.59) | 0.3643 |
| T-score lumbar spine, mean (SD) | − 1.81 (0.86) | − 1.77 (0.52) | − 1.86 (0.54) | 0.5853 |
| EQ-VAS, mean (SD) | 85.3 (10.5) | 75.0 (15.6) | 78.5 (15.2) | 0.0953 |
| EQ Index, mean (SD) | 0.94 (0.07) | 0.92 (0.08) | 0.89 (0.17) | 0.2903 |
| Isokinetic strength (60°/s) extensors [Nm], mean (SD) | 168.5 (28.3) | 122.3 (34.6) | 141.3 (43.6) | 0.0013 |
| Isokinetic strength (60°/s) flexors [Nm], mean (SD) | 93.5 (13.0) | 74.4 (23.0) | 90.0 (32.9) | 0.0173 |
| Isokinetic strength (240°/s) extensors [Nm], mean (SD) | 90.7 (16.8) | 65.7 (19.5) | 78.2 (24.0) | 0.0033 |
| Isokinetic strength (240°/s) flexors [Nm], mean (SD) | 68.7 (12.7) | 53.1 (18.5) | 62.6 (19.7) | 0.0273 |
| Balance test [ | 8.2 (3.9) | 6.0 (3.7) | 7.1 (4.7) | 0.0303 |
| MET-minutes/week, mean (SD) | 1272.3 (1159.4) | 1400.1 (956.7) | 2261.7 (2293.3) | 0.1541 |
VT vibration training group, RT resistance training group, CG control group, SD standard deviation, VAS visual analogue scale, MET metabolic equivalent
1One-way ANOVA
2Pearson chi-square test
3Kruskal–Wallis test
Between-groups analyses of baseline to 12 month follow-up T-score delta values
| Number of participants (VT/RT/CG) | VT | RT | CG | ||
|---|---|---|---|---|---|
| T-score total hip left, mean differences (SD)2 | 18/22/20 | 0.08 (0.32) | 0.02 (0.16) | 0.07 (0.19) | 0.313 |
| T-score total hip left, mean differences (SD)3 | 16/19/18 | 0.09 (0.34) | 0.04 (0.20) | 0.08 (0.20) | 0.432 |
| T-score total hip left, mean differences (SD)4 | 16/18/17 | 0.09 (0.34) | 0.02 (0.17) | 0.07 (0.20) | 0.280 |
| T-score lumbar spine, mean differences (SD)2 | 18/22/21 | − 0.08 (0.38) | − 0.04 (0.27) | 0.03 (0.25) | 0.165 |
| T-score lumbar spine, mean differences (SD)3 | 16/19/19 | − 0.09 (0.40) | − 0.05 (0.29) | 0.04 (0.26) | 0.177 |
| T-score lumbar spine, mean differences (SD)4 | 15/18/18 | − 0.17 (0.22) | − 0.04 (0.30) | 0.02 (0.26) | 0.119 |
SD standard deviation, VT vibration training group, RT resistance training group, CG control group
1Kruskal–Wallis test to compare the delta values (T0 baseline – T12 end of interventions)
2Intention-to-treat analysis
3Per-protocol analysis
4Sensitive analysis: statistical analysis without outliers
Fig. 3Bone mineral density of the left hip and lumbar spine before (T0) and at the end of intervention (T12) in the vibration training (VT) group, the resistance training (RT) group, and the control group (CG). Individual values are presented together with means ± SD according to the intention-to-treat analysis
Within-groups analyses of T-score values from baseline to 12-month follow-up
| T-score total hip left, T0 (SD) | T-score total hip left, T12 (SD) | Mean difference within group (SD) | ||
|---|---|---|---|---|
| VT ( | − 1.16 (0.62) | − 1.26 (0.71) | 0.10 (0.34) | 0.292 |
| RT ( | − 0.82 (0.69) | − 0.84 (0.62) | 0.02 (0.17) | 0.507 |
| CG ( | − 0.96 (0.61) | − 1.03 (0.54) | 0.07 (0.20) | 0.115 |
| T-score lumbar spine, T0 mean (SD) | T-score lumbar spine, T12 mean (SD) | |||
| VT ( | − 1.83 (0.91) | − 1.74 (0.72) | − 0.09 (0.40) | 0.399 |
| RT ( | − 1.80 (0.54) | − 1.75 (0.58) | − 0.05 (0.29) | 0.490 |
| CG ( | − 1.84 (0.56) | − 1.88 (0.66) | 0.04 (0.26) | 0.494 |
Mean difference within group: negative values indicate an improvement
T0 baseline, T12 end of interventions, SD standard deviation, VT vibration training group, RT resistance training group, CG control group
1Paired t test
Within-groups analyses of secondary endpoints over all measurement times
| Outcome measures | T0 median | T6 median | T12 median | T15 median | Df | Chi-square | |
|---|---|---|---|---|---|---|---|
| Isokinetic strength (60°/s) extensors [Nm] | |||||||
| VT ( | 171 (154–185) | 179 (167–201) | 191 (164–203) | 186 (156–202) | 3 | 12.920 | 0.005 |
| RT ( | 112 (102–155) | 134 (121–157) | 155 (131–175) | 142 (121–161) | 3 | 11.635 | 0.009 |
| CG ( | 142 (93–184) | 137 (107–171) | 153 (120–185) | 149 (115–197) | 3 | 7.473 | 0.058 |
| Isokinetic strength (60°/s) flexors [Nm] | |||||||
| VT ( | 93 (83–102) | 105 (90–117) | 100 (92–113) | 100 (97–117) | 3 | 11.640 | 0.009 |
| RT ( | 71 (62–91) | 85 (69–97) | 92 (80–106) | 94 (80–106) | 3 | 32.048 | > 0.000 |
| CG ( | 85 (55–119) | 97 (66–119) | 93 (69–128) | 101 (76–132) | 3 | 8.506 | 0.037 |
| Isokinetic strength (240°/s) extensors [Nm] | |||||||
| VT ( | 91 (77–105) | 100 (88–112) | 99 (88–109) | 100 (94–109) | 3 | 11.400 | 0.010 |
| RT ( | 66 (53–77) | 83 (65–94) | 83 (73–92) | 84 (69–88) | 3 | 20.116 | > 0.000 |
| CG ( | 82 (56–99) | 78 (60–96) | 87 (68–107) | 94 (76–106) | 3 | 15.071 | 0.002 |
| Isokinetic strength (240°/s) flexors [Nm] | |||||||
| VT ( | 64 (59–81) | 75 (62–82) | 73 (71–81) | 78 (66–81) | 3 | 6.600 | 0.058 |
| RT ( | 54 (43–64) | 59 (52–77) | 63 (51–78) | 65 (53–76) | 3 | 20.495 | > 0.000 |
| CG ( | 70 (43–79) | 63 (50–84) | 69 (48–89) | 74 (57–87) | 3 | 13.024 | 0.005 |
| EQ-VAS | |||||||
| VT ( | 88 (78–91) | 90 (80–91) | 85 (80–91) | 90 (80–96) | 3 | 0.559 | 0.906 |
| RT ( | 80 (70–90) | 80 (80–90) | 85 (80–90) | 90 (78–91) | 3 | 8.165 | 0.043 |
| CG ( | 80 (73–89) | 80 (73–89) | 80 (70–90) | 80 (73–90) | 3 | 6.062 | 0.109 |
| EQ Index | |||||||
| VT ( | 1.00 (0.89–1.00) | 1.00 (0.89–1.00) | 1.00 (0.89–1.00) | 1.00 (0.89–1.00) | 3 | 3.643 | 0.303 |
| RT ( | 0.89 (0.89–1.00) | 0.89 (0.89–1.00) | 1.00 (0.89–1.00) | 1.00 (0.89–1.00) | 3 | 4.948 | 0.176 |
| CG ( | 0.89 (0.89–1.00) | 0.89 (0.89–1.00) | 0.89 (0.89–1.00) | 0.89 (0.89–1.00) | 3 | 1.957 | 0.581 |
| Balance test [ | |||||||
| VT ( | 6 (5–13) | 6 (-14) | 13 (7–14) | 10 (5–14) | 3 | 6.247 | 0.100 |
| RT ( | 5 (5–8) | 6 (5–13) | 6 (5–14) | 5 (5–13) | 3 | 16.895 | 0.001 |
| CG ( | 5 (5–14) | 5 (5–14) | 5 (5–14) | 5 (5–6) | 3 | 6.507 | 0.089 |
Df degree of freedom, VT vibration training group, RT resistance training group, CG control group, T0 baseline, T6 intermediary, T12 end of interventions, T15 follow-up
1Friedman test